Actionable news
All posts from Actionable news
Actionable news in BMY: BRISTOL-MYERS SQUIBB CO.,

Bristol-Myers and Clovis will partner for cancer combination trials

Bristol-Myers Squibb Co. BMY, +1.90% and Clovis Oncology Inc. CLVS, +6.25% plan to work together to test a combination of Bristol-Myers' drug Opdivo and Clovis' drug Rubraca in cancer clinical trials. Shares of Clovis were up 2% in premarket trade Monday while Bristol-Myers shares declined...